Why supply chains fail at launch: It’s not the plan, it’s the execution

Patent cliff pharmaceutical launches expose a persistent supply chain gap. Organizations invest heavily in demand planning, scenario modeling, and S&OP processes but still miss revenue targets by 30% to 50% in the first six months post-launch.

The culprit is rarely forecast accuracy or manufacturing capacity. It is the absence of execution infrastructure: the operating system that converts supply visibility into prioritized allocation decisions, real-time tradeoffs, and accountable outcomes. For supply chain leaders managing high-stakes launches under constrained capacity, execution infrastructure determines whether market opportunity becomes realized revenue or slips to faster competitors. This article presents a practical framework supply chain leaders can implement before the next launch wave arrives.

The launch moment when plans meet reality

Every major pharmaceutical product launch begins with a solid supply plan. Demand forecasts are validated. Manufacturing schedules are locked. Safety stock levels are agreed upon. Distribution partners are briefed. The readiness checklist is complete.

Then the product launches, and within three weeks, the plan starts to unravel.

A competitor misses supply, and demand spikes 40% above forecast in one region. A strategic hospital system accelerates orders while another delays due to internal pharmacy committee approvals. A key distributor places a large order for opportunistic accounts while contracted Tier 1 customers wait for allocation. The supply team has full visibility. Dashboards show inventory by SKU and location. Forecast variance is still within the acceptable range.

Yet revenue starts falling behind projection.

The gap is not information. It is execution. Inventory exists but reaches the wrong customers at the wrong time. Allocation decisions stall in cross-functional reviews. Commercial priorities shift faster than supply plans update. Finance escalates margin concerns after product has already shipped. By week eight, high-value contracted accounts have an inconsistent supply and begin switching to competitors. The launch window closes. The revenue gap becomes structural.

I have observed this pattern across multiple pharmaceutical and healthcare product launches. The root cause is consistent. Organizations treat supply chain readiness as a planning problem when it is fundamentally an execution problem. They build forecasting capability without building the decision architecture, integration cadence, and accountability mechanisms required to act at launch velocity.

Why analytics without execution infrastructure fail

Most pharmaceutical supply chains are analytically mature. Teams can model demand scenarios, simulate capacity constraints, and project service level impacts with precision. During high-stakes launches, that capability is necessary but insufficient.

Explore more on this topic at the NextGen Supply Chain Conference

 

When Plans Fail: Building the Execution Infrastracture for Supply Chain Success

Most organizations invest heavily in forecasting, planning, visibility, and analytics, yet many still struggle when market conditions change and execution decisions must be made in real time. The challenge is rarely a lack of data. It is a lack of decision-making frameworks, accountability, and cross-functional alignment that turn insights into action.

In this special NextGen Supply Chain Conference session, Rahul Mittal, head of strategy & innovations for Dr. Reddy's Laboratories, will explore the concept of execution infrastructure—the governance, decision rights, operating rhythms, and integration mechanisms that enable organizations to respond quickly under pressure. Attendees will learn practical strategies for improving decision velocity, aligning supply with business priorities, and building supply chains that execute as effectively as they plan.

Register to attend today

 

Analytics answer what is happening. Execution infrastructure answers what we do next and who owns it.

Without execution infrastructure, insights do not convert to action. Allocation reports highlight imbalances but do not trigger reallocation. Supply risk dashboards flag constraints but do not resolve prioritization conflicts. Escalations reach leadership but stall because decision rights are unclear.

In launch environments, decision velocity matters more than analytical precision. A directionally correct allocation decision executed in 24 hours captures more value than a perfectly optimized decision that takes two weeks. Supply chains that win launches are not necessarily the most analytically sophisticated. They are the most decisive and the most tightly integrated with commercial and finance operations.

The 4 components of supply chain execution infrastructure

Execution infrastructure for supply chain teams consists of four interconnected elements that translate supply visibility into business outcomes.

1. Decision architecture: Clear ownership of allocation under constraint

When demand exceeds supply during a launch, allocation becomes the most critical supply chain decision. Many organizations avoid explicit prioritization, defaulting to proportional allocation across all demand to maintain perceived fairness.

Proportional allocation is expensive. It spreads constrained inventory across high-value contracted customers and low-margin opportunistic orders equally, satisfying no one fully and eroding both revenue and customer loyalty.

Decision architecture establishes three things before the launch:

1. Single decision owner. One leader, typically the head of supply planning or VP of supply chain operations, owns allocation decisions across customers, channels, and geographies. Not a committee. Not a consensus process. One accountable executive with clear authority to make tradeoffs.
2. Transparent prioritization framework. Allocation follows explicit criteria tied to business value. A typical framework might prioritize Tier 1 contracted Group Purchasing Organization accounts over non-contracted wholesale demand, customers with demonstrated compliance history over sporadic buyers, and strategic health system partnerships over transactional volume even when short-term margins are lower.
3. Defined decision inputs. The decision owner receives real-time data on contract tier status, customer margin contribution, compliance rates, competitive supply position, and strategic relationship value. Analytics provide the scoring. The owner makes the call.

The value of decision architecture is velocity and clarity. When a supply constraint emerges three weeks post-launch, the organization does not convene cross-functional debates. The decision owner reviews current data, applies the prioritization framework, communicates the allocation, and execution proceeds within 24 hours.

2. Real-time supply demand integration loops

Launch plans assume linearity. Launch reality delivers volatility. Competitor actions shift demand. Manufacturing yields vary. Customer ordering patterns concentrate unexpectedly. Without real-time integration between supply signals and commercial priorities, supply chains react too slowly to capture opportunity or mitigate risk.

Integration loops embed joint decision-making into daily operating cadence during launch windows. This typically takes the form of a 30-minute daily standup meeting with fixed participation from supply planning, commercial operations, and finance.

Supply planning updates inventory positions by product, location, and customer segment. Commercial operations provide order pipeline visibility and customer demand signals. Finance presents margin implications by channel and customer tier. Together, the group answers three questions. Where is demand shifting relative to plan? Where is supply becoming constrained? What reallocation decisions do we execute today?

No slides. No formal presentations. Data, diagnosis, decision.

This loop transforms supply planning from a weekly batch process into a continuous integration engine. Inventory moves with commercial opportunities, not static allocation plans locked weeks prior.

3. Structured operating rhythm and cross-functional governance

Patent cliff launches require coordination across supply planning, manufacturing, procurement, quality, logistics, commercial operations, finance, and regulatory. Without structured rhythm, coordination degrades into fragmented email threads, overlapping calls, and delayed decisions.

A Launch Supply Readiness Council provides the governing rhythm. The council meets weekly in the 12 weeks preceding and 12 weeks following each major launch. Membership includes supply chain leadership, manufacturing operations, commercial operations, finance, and analytics.

The agenda is consistent across every meeting. Review supply service levels by customer tier and product. Assess allocation adherence to the prioritization framework. Diagnose variances from the plan. Identify risks emerging in the next two weeks. Assign corrective actions with named owners and committed due dates. Track the closure status of prior actions.

The meeting runs 60 minutes. Decisions are documented in real time. Actions are tracked in a shared system visible to all stakeholders. Overdue actions escalate automatically to executive leadership.

Additionally, a Supply Allocation Forum meets twice weekly during active launches to make real-time tradeoff decisions. Should we fulfill a large order from a low-margin distributor today or reserve that inventory for a contracted high-margin health system ordering next week? The forum decides based on the pre-agreed allocation framework.

Structured rhythm eliminates the chaos that typically surrounds launches. Teams know when decisions will be made, who will make them, and how actions will be tracked.

4. Transparent accountability and execution tracking

Accountability in execution infrastructure means every supply decision and corrective action has a named owner, a committed due date, and visible status. Performance transparency means execution is measured and reviewed as rigorously as forecast accuracy.

For patent cliff launches, this includes several mechanisms.

Supply execution scorecards track on-time, in-full delivery performance by product and customer tier, backorder levels and aging, adherence to allocation prioritization framework, and supply plan accuracy versus actual. Scorecards are reviewed weekly in the Launch Supply Readiness Council and distributed to executive leadership.

Action closure dashboards display all open actions from governance forums, assigned owners, due dates, and current status. Closure rates become a team performance metric. High-performing supply chain teams close 85% to 90% of committed actions on time. Teams without execution discipline close 50% or less.

Allocation decision logs document every allocation decision made during constrained supply periods, including rationale, data inputs, decision owner, and subsequent outcome. This creates organizational learning. When an allocation proves effective, the logic is captured and applied to future decisions. When an allocation underperforms, the team diagnoses the gap and refines the framework.

Accountability is not punitive. It is clarity. When every team member knows who owns what and how success is measured, execution accelerates and finger pointing disappears.

Where supply chains lose value during launches

Across failed patent cliff launches, three patterns emerge consistently.

1. Allocation without strategic prioritization. Supply teams treat all demand as equivalent to avoid difficult conversations. High-value contracted accounts compete equally with low-margin opportunistic orders. The result is diffused inventory, unmet contracted commitments, and damaged customer relationships.
2. Slow integration between supply and commercial operations. Supply planning operates on weekly or biweekly cycles while commercial priorities shift daily based on competitor moves and customer pipeline changes. By the time supply reallocates inventory, the commercial opportunity has closed.
3. Ambiguous decision ownership. Allocation decisions create winners and losers, which organizations avoid by seeking consensus or deferring to committees. Decision velocity collapses. Value erodes to competitors who decide faster.

Supply chains with strong execution infrastructure avoid these failure modes. They allocate strategically, integrate in real time, and decide quickly. They treat supply chain execution as competitive advantage, not support function.

Measuring what matters in launch execution

Execution infrastructure should be measured by business outcomes, not process compliance. Three metrics reveal execution strength.

1. Allocation effectiveness. What percentage of constrained supply reaches high-value contracted customers versus low-margin opportunistic demand in the first 90 days post-launch. Strong performers direct 75% to 85% of launch inventory to priority accounts. Organizations without prioritization frameworks allocate 40% to 50%.
2. Decision velocity. How quickly does a supply constraint trigger a reallocation decision and execution? Best-in-class organizations complete the cycle within 24 to 48 hours. Organizations without decision architecture require 7 to 14 days.
3. Service level performance by customer tier. Are Tier 1 contracted customers experiencing materially better on-time, in-full performance than non-contracted accounts? This metric reveals whether allocation prioritization exists on paper only or drives actual execution.

What supply chain leaders should do now

If you are leading supply chain operations in pharmaceuticals, medical devices, or healthcare manufacturing and preparing for major product launches, four actions build execution infrastructure before the launch arrives.

1. First, assign a single allocation decision owner now. Define who makes the call when demand exceeds supply. Clarify decision authority, required data inputs, and prioritization criteria. Eliminate ambiguity before constraints appear.
2. Second, establish daily supply demand integration during launch windows. Create a 30-minute daily standup where supply planning, commercial operations, and finance review demand signals, supply positions, and make reallocation decisions in real time. No presentations. Just data, diagnosis, and decisions.
3. Third, build a structured launch operating rhythm. Launch a weekly Supply Readiness Council that meets during critical launch periods with a consistent agenda, clear decision rights, and disciplined action tracking. Treat the forum as a decision engine, not a status update meeting.
4. Fourth, measure allocation effectiveness and decision velocity, not just forecast accuracy. Track where constrained inventory actually flows and how quickly allocation decisions execute. Reward teams for strategic, timely tradeoffs, not just utilization or plan adherence.

Patent cliff launches are execution stress tests for supply chains. Organizations with strong execution infrastructure convert constrained supply into revenue capture and strengthened customer relationships. Organizations relying on good intentions and heroic effort watch value shift to competitors who execute faster and make clearer decisions.

Supply chain analytics tell you what is happening. Execution infrastructure determines whether you capture the value before the window closes.

About the author

Rahul Mittal is head, strategy & innovations for Dr. Reddy's Laboratories, Inc., a global pharmaceutical company producing over 190 medications for global clients.

SC
MR